期刊文献+

早发冠心病并发高血压病患者血浆结合珠蛋白水平与冠状动脉病变程度的相关性

Clinical significance of plasma haptoglobin levels in patients with premature coronary heart disease with essential hypertension
原文传递
导出
摘要 目的:分析早发冠心病并发高血压病患者血浆结合珠蛋白(haptoglobin,Hp)水平的变化及其与冠状动脉病变严重程度的相关性。方法:经冠脉造影确诊的早发冠心病患者90例,非冠心病的健康体检者90例作为对照组,据血压水平分类将90例早发冠心病患者分为3个亚组:正常血压及正常高值亚组(亚组1)、Ⅰ级和Ⅱ级高血压亚组(亚组2)、Ⅲ级高血压亚组(亚组3)。检测血浆Hp浓度,比较冠心病组与对照组血浆Hp浓度的差异;分析早发冠心病不同临床亚组间血浆Hp浓度、Gensini积分的差异及分析二者的相关性。结果:早发冠心病组的血浆Hp浓度明显高于对照组,比较有统计学差异(P<0.01)。早发冠心病组3个亚组的Hp血浆浓度分别为(1.6±0.5)μg/L、(1.7±0.4)μg/L和(2.0±0.6)μg/L,3组之间差异有统计学意义(P<0.05)。两两比较,亚组3的Hp血浆浓度高于亚组1和亚组2,差别有统计学意义(均P<0.05)。3个亚组Gensini积分分别为(32±19)、(33±18)和(48±28),3亚组之间差异有统计学意义(P<0.05)。两两比较,亚组3的Gensini积分高于亚组1和亚组2,差别有统计学意义(均P<0.05),而亚组1与亚组2的Hp浓度和Gensini积分均无显著差异。结论:Hp水平的升高与早发冠心病的发生及冠脉狭窄的严重程度有关。 AIM: To investigate the clinical significance of the variations of blood plasma haptoglobin (Hp) in premature coronary heart disease (PCAD) patients with essential hypertension and to study the clinical correlations between the level of plasma Hp and PACD-essential hypertension. METHODS: Ninety patients with PACD confirmed by coronary angiography were enrolled in this study and 90 healthy subjects were selected as control. According to the levels of blood pressure (Bp), the patients were divided into three groups: normal Bp group, Grade 1 Bp and Grade 2 group, and Grade 3 Bp group. Plasma levels of Hp were detected, plasma Hp levels between PACD groups and control group were compared and plasma Hp levels and Gensini scores and their correlation were analyzed in the three groups. RESULTS: Plasma levels of Hp in patients with PACD were significantly higher than the levels in control subjects (P 〈 0. 05). Plasma levels of Hp in the three PACD groups were ( 1.6± 0. 5 ) ng/ml, ( 1.7±0. 4) ng/ml and (2.0± 0.6) ng/ml, respectively, with significant differences among the three groups(P 〈 0. 05). Gensini scores in the three PACD groups were 32 ± 19, 33 ±18 and 48± 28, respectively, with significant difference among the three groups ( P 〈 0. 05 ). The plasma level of Hp and Gensini score in Grade 3 group was higher than the level in the other two groups (P 〈 0. 05 ). CONCLUSION : Plas- ma Hp level has some clinical significance for diagnosis of PACD and assessment of degree of coronary stenosis along with its correlation with the development and advancement of PACD and with the degree of coronary stenosis.
出处 《心脏杂志》 CAS 2013年第1期70-72,共3页 Chinese Heart Journal
基金 青岛市科研基金资助(2008014)
关键词 冠状动脉疾病 结合珠蛋白 高血压 原发性 coronary disease haptoglobin essential hypertension
  • 相关文献

参考文献10

  • 1方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 2Kristiansen M, Graversen JH, Jacobsen C, et al. Identification of the hemoglobin scavenger receptor [ J ]. Nature, 2001,409 ( 6817 ) : 198 -201.
  • 3Wassell J. Haptoglobin : function and polymorphism [ J ]. Clin Lab, 2000, 46(11 - 12) :547 -552.
  • 4Gensini GG. A more meaningful scoring system for determining the Severity of coronary heart disease [ J]. Am J Cardiol, 1983, 51 (3) :606.
  • 5Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans [ J]. Clin Chem, 1996, 42 (10) :1589 - 1600.
  • 6Maes M, Ruckoanich P, Chang YS, et al. Multiple aberrations in shared inf-ammatory and oxidative and nitrosative stress (I0 and NS) pathways explain the co-association of depression and cardiovascular sorder( CVD), and the increased risk for CVD and due mortality in depressed patients [ J ]. ProgNeuropsyehopharmacol Bid Psychiatry, 2011, 35(3) :769 -783.
  • 7Blum S, Asaf R, Guetta J, et al. Haptoglobin genotype determines myocardia infarct size in diabetiet mice [ J ]. J Am Coil Cardiol, 2007. 49 ( 1 ) :82 - 87.
  • 8陈丽,韩雅玲,荆全民,王效增,李毅,鄢高亮,张磊,霍勇,张岩.高血压与冠状动脉狭窄程度的相关性研究[J].解放军医学杂志,2011,36(4):327-330. 被引量:28
  • 9Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist [ J ]. Am Heart Association, 2002, 105 ( 5 ) :546 - 549.
  • 10闫奎坡,王滢.高血压与冠心病的关系研究进展[J].亚太传统医药,2009,5(6):140-141. 被引量:14

二级参考文献21

  • 1Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol, 1983, 51 (3): 606.
  • 2Danese C, Vestri AR, DAlfonso V, et al. Do hypertension and diabetes mellitus influence the site of atherosclerotic plaques[J]. Clin Ter, 2006, 157(1): 9-13.
  • 3Arslan F, Kaya MG, van der Heijden G, et al. Hypertension as a predictor of adverse cardiac events in patients with borderline frac"~ional flow reserve[J]. Acta Cardiol, 2007, 62(4): 367-372.
  • 4Gray GA, L6ffier BM, Ciozel 1VL Characterization of endothelin receptors mediating contraction of rabbit saphinous vein[J]. Am J Physiol, 1994, 266(3 Pt 2): H959-H966.
  • 5Falcone C, Nespoli L, Geroldi D, et al. Silent myocardial ischemia in diabetic and nondiabetic patientswith coronary artery disease[J].Int J Cardiol, 2003, 90(2/3): 219-227.
  • 6Mylonas C, Kouretas D. Lipid peroxidation and tissue damage[J]. In Vivo, 1999, 13(3): 295-309.
  • 7Ross R. Atherosclerosis -- an inflammatory disease[J]. N Engl J Med, 1999, 340(2): 115-126.
  • 8Mayer M. Assocition of serun bilirubin concentration with risk of coronary artery disease[J]. Clin Chem, 2000, 46(11) : 1723-1727.
  • 9Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery dis- ease[J]. Clin Chem, 1994, 40(1): 18-23.
  • 10龚卫琴,赵连友,郑昌柱,李源,崔致贤.老年高血压并左室肥厚患者冠脉狭窄改变的特点及其临床意义[J].高血压杂志,1997,5(3):205-207. 被引量:6

共引文献3105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部